These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 30567901)
1. Development of an Opsonophagocytic Killing Assay Using HL-60 Cells for Detection of Functional Antibodies against Salehi S; Hohn CM; Penfound TA; Dale JB mSphere; 2018 Dec; 3(6):. PubMed ID: 30567901 [TBL] [Abstract][Full Text] [Related]
2. Development of an opsonophagocytic killing assay for group a streptococcus. Jones S; Moreland NJ; Zancolli M; Raynes J; Loh JMS; Smeesters PR; Sriskandan S; Carapetis JR; Fraser JD; Goldblatt D Vaccine; 2018 Jun; 36(26):3756-3763. PubMed ID: 29776751 [TBL] [Abstract][Full Text] [Related]
3. An Opsonophagocytic Killing Assay for the Evaluation of Group A Streptococcus Vaccine Antisera. McGregor R; Jones S; Jeremy RM; Goldblatt D; Moreland NJ Methods Mol Biol; 2020; 2136():323-335. PubMed ID: 32430834 [TBL] [Abstract][Full Text] [Related]
4. Opsonophagocytic Killing Assay to Measure Anti-Group A Streptococcus Antibody Functionality in Human Serum. Wagstaffe H; Jones S; Johnson M; Goldblatt D Methods Mol Biol; 2022; 2414():373-386. PubMed ID: 34784047 [TBL] [Abstract][Full Text] [Related]
5. A new flow-cytometry-based opsonophagocytosis assay for the rapid measurement of functional antibody levels against Group B Streptococcus. Fabbrini M; Sammicheli C; Margarit I; Maione D; Grandi G; Giuliani MM; Mori E; Nuti S J Immunol Methods; 2012 Apr; 378(1-2):11-9. PubMed ID: 22309986 [TBL] [Abstract][Full Text] [Related]
6. Opsonic antibodies to the surface M protein of group A streptococci in pooled normal immunoglobulins (IVIG): potential impact on the clinical efficacy of IVIG therapy for severe invasive group A streptococcal infections. Basma H; Norrby-Teglund A; McGeer A; Low DE; El-Ahmedy O; Dale JB; Schwartz B; Kotb M Infect Immun; 1998 May; 66(5):2279-83. PubMed ID: 9573118 [TBL] [Abstract][Full Text] [Related]
7. Development of a multiplexed opsonophagocytic killing assay (MOPA) for group B Streptococcus. Choi MJ; Noh JY; Cheong HJ; Kim WJ; Lin SM; Zhi Y; Lim JH; Lim S; Seo HS; Song JY Hum Vaccin Immunother; 2018 Jan; 14(1):67-73. PubMed ID: 28933634 [TBL] [Abstract][Full Text] [Related]
8. Establishment of a modified opsonophagocytic killing assay for anti-pneumococcal surface protein A antibody. Kuroda E; Koizumi Y; Piao Z; Nakayama H; Tomono K; Oishi K; Hamaguchi S; Akeda Y J Microbiol Methods; 2023 Sep; 212():106804. PubMed ID: 37543109 [TBL] [Abstract][Full Text] [Related]
9. Type-specific opsonophagocytosis of group A Streptococcus by use of a rapid chemiluminescence assay. Villaseñor-S A; Bryant AE; Stevens DL J Infect Dis; 1999 May; 179(5):1293-6. PubMed ID: 10191240 [TBL] [Abstract][Full Text] [Related]
10. The importance of the location of antibody binding on the M6 protein for opsonization and phagocytosis of group A M6 streptococci. Jones KF; Fischetti VA J Exp Med; 1988 Mar; 167(3):1114-23. PubMed ID: 2450950 [TBL] [Abstract][Full Text] [Related]
11. New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci. Dale JB; Penfound TA; Chiang EY; Walton WJ Vaccine; 2011 Oct; 29(46):8175-8. PubMed ID: 21920403 [TBL] [Abstract][Full Text] [Related]
12. Invasive Streptococcal Infection Can Lead to the Generation of Cross-Strain Opsonic Antibodies. de Neergaard T; Bläckberg A; Ivarsson H; Thomasson S; Kumra Ahnlide V; Chowdhury S; Khakzad H; Bahnan W; Malmström J; Rasmussen M; Nordenfelt P Microbiol Spectr; 2022 Dec; 10(6):e0248622. PubMed ID: 36314947 [TBL] [Abstract][Full Text] [Related]
13. Development of a high-throughput opsonophagocytic assay for the determination of functional antibody activity against Streptococcus pyogenes using bioluminescence. Lorenz N; Loh JM; Moreland NJ; Proft T J Microbiol Methods; 2017 Mar; 134():58-61. PubMed ID: 28115206 [TBL] [Abstract][Full Text] [Related]
14. Serum opacity factor (SOF) of Streptococcus pyogenes evokes antibodies that opsonize homologous and heterologous SOF-positive serotypes of group A streptococci. Courtney HS; Hasty DL; Dale JB Infect Immun; 2003 Sep; 71(9):5097-103. PubMed ID: 12933852 [TBL] [Abstract][Full Text] [Related]
15. Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells. Romero-Steiner S; Libutti D; Pais LB; Dykes J; Anderson P; Whitin JC; Keyserling HL; Carlone GM Clin Diagn Lab Immunol; 1997 Jul; 4(4):415-22. PubMed ID: 9220157 [TBL] [Abstract][Full Text] [Related]
16. Type III group B streptococcal strain differences in susceptibility to opsonization with human serum. Fischer GW; Hunter KW; Wilson SR Pediatr Res; 1981 Dec; 15(12):1525-9. PubMed ID: 7033908 [TBL] [Abstract][Full Text] [Related]
17. Safety and immunogenicity of a 30-valent M protein-based group a streptococcal vaccine in healthy adult volunteers: A randomized, controlled phase I study. Pastural É; McNeil SA; MacKinnon-Cameron D; Ye L; Langley JM; Stewart R; Martin LH; Hurley GJ; Salehi S; Penfound TA; Halperin S; Dale JB Vaccine; 2020 Feb; 38(6):1384-1392. PubMed ID: 31843270 [TBL] [Abstract][Full Text] [Related]
18. Opsonic human antibodies from an endemic population specific for a conserved epitope on the M protein of group A streptococci. Brandt ER; Hayman WA; Currie B; Carapetis J; Wood Y; Jackson DC; Cooper J; Melrose WD; Saul AJ; Good MF Immunology; 1996 Nov; 89(3):331-7. PubMed ID: 8958044 [TBL] [Abstract][Full Text] [Related]
19. Binding of human plasma proteins to Streptococcus pyogenes M protein determines the location of opsonic and non-opsonic epitopes. Sandin C; Carlsson F; Lindahl G Mol Microbiol; 2006 Jan; 59(1):20-30. PubMed ID: 16359315 [TBL] [Abstract][Full Text] [Related]
20. Antibodies specific for the high-molecular-weight adhesion proteins of nontypeable Haemophilus influenzae are opsonophagocytic for both homologous and heterologous strains. Winter LE; Barenkamp SJ Clin Vaccine Immunol; 2006 Dec; 13(12):1333-42. PubMed ID: 17021246 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]